Key statistics dashboard for enVVeno Medical Corporation (NVNO). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions.
Stock Data
| Price | $9.05 |
| Market Cap | $0M |
| Enterprise Value | -$2.2M |
| Beta | 1.09 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.02 |
| Price / Book | 0.30 |
| P/S | 0.00 |
| EV/EBITDA | 0.14 |
| EV/Sales | 0.00 |
| EV/FCF | 0.15 |
| P/FCF | -0.01 |
| Earnings Yield | -258.94% |
| FCF Yield | -9790.29% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -62.28% |
| Return on Assets | -69.39% |
| Return on Invested Capital | -79.12% |
| Return on Capital Employed | -80.65% |
Financial Health
| Current Ratio | 11.70 |
| Quick Ratio | 11.70 |
| Cash Ratio | 1.51 |
| Debt / Equity | 0.02 |
| Debt / Assets | 2.23% |
| Net Debt / EBITDA | 0.15 |
| Interest Coverage | 0.00 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 30.80 |
| Cash per share | 32.02 |
| FCF per share | -21.79 |
| Tangible Book Value per share | 30.80 |
| Dividend per share | 0.00 |
Related companies: ADGM · AEMD · ALUR · AYTU · COCH · CODX · EKSO
Explore sector: Healthcare · Medical - Devices
More sections of NVNO: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks